Company Overview of Koronis Pharma, Inc.
Koronis Pharma, Inc., a biotechnology company, develops antiviral therapeutics based on Viral Decay Acceleration mechanism. It develops KP-1461 for the treatment of HIV virus; and products for the treatment of antiviral infections. The company was founded in 1998 and is based in Seattle, Washington.
500 Union Street
Seattle, WA 98101
Founded in 1998
Key Executives for Koronis Pharma, Inc.
Similar Private Companies By Industry
|ProdiGene, Inc.||United States|
|Genyous Life Sciences||United States|
|OroGen Bio Sciences, Inc.||United States|
|C2 Therapeutics, Inc.||United States|
|Adaptive Symbiotic Technologies LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Koronis Pharma, Inc., please visit www.koronispharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.